Oncogenic Herpesvirus KSHV Hijacks BMP-Smad1-Id Signaling to Promote Tumorigenesis

English version České info

Although KSHV exerts multiple mechanisms to promote cell survival by repressing TGF-β signaling, little is known whether KSHV manipulates BMP signaling and contributes to the pathogenesis of KSHV-induced malignancies. In the present study, we have identified Smad1 as a novel binding protein of LANA by tandem affinity purification. We demonstrated that LANA up-regulated Id transcription through BMP-Smad1-Id signaling pathway. Id proteins were significantly up-regulated in KSHV-transformed MM (KMM) cells, and were abundantly expressed in human KS lesions; therefore, they were probably relevant to the development of KS. Importantly, we have shown that Ids are required to maintain the oncogenic phenotype of KMM cells in vitro and in vivo. These findings illustrate a novel mechanism by which a tumor virus hijacks and converts a developmental pathway into an indispensable oncogenic pathway for tumorigenesis. Furthermore, we showed that BMP signaling inhibitors dramatically hampered the tumorigenicity of KMM cells in vitro and in vivo. Our results demonstrate that small inhibitors targeting BMP-Smad1-Id signaling pathway are promising candidates for the treatment of KS.

Vyšlo v časopise: Oncogenic Herpesvirus KSHV Hijacks BMP-Smad1-Id Signaling to Promote Tumorigenesis. PLoS Pathog 10(7): e32767. doi:10.1371/journal.ppat.1004253
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004253

Souhrn

Zdroje

1. GanemD (2010) KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J Clin Invest 120: 939–949.

2. MesriEA, CesarmanE, BoshoffC (2010) Kaposi's sarcoma and its associated herpesvirus. Nat Rev Cancer 10: 707–719.

3. BallestasME, KayeKM (2011) The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency. Future Microbiol 6: 1399–1413.

4. VermaSC, LanK, RobertsonE (2007) Structure and function of latency-associated nuclear antigen. Curr Top Microbiol Immunol 312: 101–136.

5. LanK, VermaSC, MurakamiM, BajajB, KaulR, et al. (2007) Kaposi's sarcoma herpesvirus-encoded latency-associated nuclear antigen stabilizes intracellular activated Notch by targeting the Sel10 protein. Proc Natl Acad Sci U S A 104: 16287–16292.

6. LanK, ChoudhuriT, MurakamiM, KuppersDA, RobertsonES (2006) Intracellular activated Notch1 is critical for proliferation of Kaposi's sarcoma-associated herpesvirus-associated B-lymphoma cell lines in vitro. J Virol 80: 6411–6419.

7. JonesT, YeF, BedollaR, HuangY, MengJ, et al. (2012) Direct and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHV. J Clin Invest 122: 1076–1081.

8. JonesT, Ramos da SilvaS, BedollaR, YeF, ZhouF, et al. (2014) Viral cyclin promotes KSHV-induced cellular transformation and tumorigenesis by overriding contact inhibition. Cell Cycle 13: 845–858.

9. MoodyR, ZhuY, HuangY, CuiX, JonesT, et al. (2013) KSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathways. PLoS Pathog 9: e1003857.

10. HoganBL (1996) Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 10: 1580–1594.

11. KelleherFC, FennellyD, RaffertyM (2006) Common critical pathways in embryogenesis and cancer. Acta Oncol 45: 375–388.

12. AlarmoEL, KallioniemiA (2010) Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis? Endocr Relat Cancer 17: R123–139.

13. PerkJ, IavaroneA, BenezraR (2005) Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer 5: 603–614.

14. SikderHA, DevlinMK, DunlapS, RyuB, AlaniRM (2003) Id proteins in cell growth and tumorigenesis. Cancer Cell 3: 525–530.

15. WongYC, WangX, LingMT (2004) Id-1 expression and cell survival. Apoptosis 9: 279–289.

16. TangJ, GordonGM, MullerMG, DahiyaM, ForemanKE (2003) Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induces expression of the helix-loop-helix protein Id-1 in human endothelial cells. J Virol 77: 5975–5984.

17. GloecknerCJ, BoldtK, SchumacherA, RoepmanR, UeffingM (2007) A novel tandem affinity purification strategy for the efficient isolation and characterisation of native protein complexes. Proteomics 7: 4228–4234.

18. MiyazonoK, KamiyaY, MorikawaM (2010) Bone morphogenetic protein receptors and signal transduction. J Biochem 147: 35–51.

19. SunR, LiangD, GaoY, LanK (2014) Kaposi's Sarcoma-Associated Herpesvirus-Encoded LANA Interacts with Host KAP1 to Facilitate Establishment of Viral Latency. J Virol 88: 7331–7344.

20. GaoSJ, KingsleyL, HooverDR, SpiraTJ, RinaldoCR, et al. (1996) Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 335: 233–241.

21. WangL, LiuYT, HaoR, ChenL, ChangZ, et al. (2011) Molecular mechanism of the negative regulation of Smad1/5 protein by carboxyl terminus of Hsc70-interacting protein (CHIP). J Biol Chem 286: 15883–15894.

22. Blanco CalvoM, Bolos FernandezV, Medina VillaamilV, Aparicio GallegoG, Diaz PradoS, et al. (2009) Biology of BMP signalling and cancer. Clin Transl Oncol 11: 126–137.

23. HollnagelA, OehlmannV, HeymerJ, RutherU, NordheimA (1999) Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J Biol Chem 274: 19838–19845.

24. KatagiriT, ImadaM, YanaiT, SudaT, TakahashiN, et al. (2002) Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes Cells 7: 949–960.

25. YuPB, HongCC, SachidanandanC, BabittJL, DengDY, et al. (2008) Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol 4: 33–41.

26. QiuH, YangB, PeiZC, ZhangZ, DingK (2010) WSS25 inhibits growth of xenografted hepatocellular cancer cells in nude mice by disrupting angiogenesis via blocking bone morphogenetic protein (BMP)/Smad/Id1 signaling. J Biol Chem 285: 32638–32646.

27. QiuH, TangW, TongX, DingK, ZuoJ (2007) Structure elucidation and sulfated derivatives preparation of two alpha-D-glucans from Gastrodia elata Bl. and their anti-dengue virus bioactivities. Carbohydr Res 342: 2230–2236.

28. VucicevicL, MisirkicM, JanjetovicK, Harhaji-TrajkovicL, PricaM, et al. (2009) AMP-activated protein kinase-dependent and -independent mechanisms underlying in vitro antiglioma action of compound C. Biochem Pharmacol 77: 1684–1693.

29. RiosM, ForetzM, ViolletB, PrietoA, FragaM, et al. (2013) AMPK activation by oncogenesis is required to maintain cancer cell proliferation in astrocytic tumors. Cancer Res 73: 2628–2638.

30. LeiX, ZhuY, JonesT, BaiZ, HuangY, et al. (2012) A Kaposi's sarcoma-associated herpesvirus microRNA and its variants target the transforming growth factor beta pathway to promote cell survival. J Virol 86: 11698–11711.

31. LiuY, SunR, LinX, LiangD, DengQ, et al. (2012) Kaposi's sarcoma-associated herpesvirus-encoded microRNA miR-K12-11 attenuates transforming growth factor beta signaling through suppression of SMAD5. J Virol 86: 1372–1381.

32. Di BartoloDL, CannonM, LiuYF, RenneR, ChadburnA, et al. (2008) KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor. Blood 111: 4731–4740.

33. DurringtonHJ, UptonPD, HoerS, BonameJ, DunmoreBJ, et al. (2010) Identification of a lysosomal pathway regulating degradation of the bone morphogenetic protein receptor type II. J Biol Chem 285: 37641–37649.

34. WangYF, WangLY, LiYL, ShyuHW, ChiouYH, et al. (2010) Human herpesvirus 8 viral FLICE-inhibitory protein retards cell proliferation via downregulation of Id2 and Id3 expression. Mol Cell Biochem 343: 83–89.

35. EverlyDNJr, MainouBA, Raab-TraubN (2004) Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation. J Virol 78: 13470–13478.

36. LiHM, ZhuangZH, WangQ, PangJC, WangXH, et al. (2004) Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells. Oncogene 23: 4488–4494.

37. LoAK, DawsonCW, LoKW, YuY, YoungLS (2010) Upregulation of Id1 by Epstein-Barr virus-encoded LMP1 confers resistance to TGFbeta-mediated growth inhibition. Mol Cancer 9: 155.

38. AlaniRM, YoungAZ, ShifflettCB (2001) Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a. Proc Natl Acad Sci U S A 98: 7812–7816.

39. OhtaniN, ZebedeeZ, HuotTJ, StinsonJA, SugimotoM, et al. (2001) Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 409: 1067–1070.

40. LasorellaA, UoT, IavaroneA (2001) Id proteins at the cross-road of development and cancer. Oncogene 20: 8326–8333.

41. VogtJ, TraynorR, SapkotaGP (2011) The specificities of small molecule inhibitors of the TGFss and BMP pathways. Cell Signal 23: 1831–1842.

42. XiaoZ, WatsonN, RodriguezC, LodishHF (2001) Nucleocytoplasmic shuttling of Smad1 conferred by its nuclear localization and nuclear export signals. J Biol Chem 276: 39404–39410.

43. QinBY, ChackoBM, LamSS, de CaesteckerMP, CorreiaJJ, et al. (2001) Structural basis of Smad1 activation by receptor kinase phosphorylation. Mol Cell 8: 1303–1312.

44. DuanX, LiangYY, FengXH, LinX (2006) Protein serine/threonine phosphatase PPM1A dephosphorylates Smad1 in the bone morphogenetic protein signaling pathway. J Biol Chem 281: 36526–36532.

45. KnockaertM, SapkotaG, AlarconC, MassagueJ, BrivanlouAH (2006) Unique players in the BMP pathway: small C-terminal domain phosphatases dephosphorylate Smad1 to attenuate BMP signaling. Proc Natl Acad Sci U S A 103: 11940–11945.

46. ZhangY, ChangC, GehlingDJ, Hemmati-BrivanlouA, DerynckR (2001) Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc Natl Acad Sci U S A 98: 974–979.

47. LiL, XinH, XuX, HuangM, ZhangX, et al. (2004) CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription. Mol Cell Biol 24: 856–864.

48. LanK, KuppersDA, VermaSC, RobertsonES (2004) Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency. J Virol 78: 6585–6594.

49. LiX, LiangD, LinX, RobertsonES, LanK (2011) Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen reduces interleukin-8 expression in endothelial cells and impairs neutrophil chemotaxis by degrading nuclear p65. J Virol 85: 8606–8615.

50. QiHH, OngusahaPP, MyllyharjuJ, ChengD, PakkanenO, et al. (2008) Prolyl 4-hydroxylation regulates Argonaute 2 stability. Nature 455: 421–424.

51. LiuY, CaoY, LiangD, GaoY, XiaT, et al. (2008) Kaposi's sarcoma-associated herpesvirus RTA activates the processivity factor ORF59 through interaction with RBP-Jkappa and a cis-acting RTA responsive element. Virology 380: 264–275.

52. FengY, WangY, WangZ, FangZ, LiF, et al. (2012) The CRTC1-NEDD9 signaling axis mediates lung cancer progression caused by LKB1 loss. Cancer Res 72: 6502–6511.